The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
Cancer Research Communications
Magistri, Marco M; Happ, Lanie E LE; Ramdial, Jeremy J; Lu, XiaoQing X; Stathias, Vasileios V; Kunkalla, Kranthi K; Agarwal, Nitin N; Jiang, Xiaoyu X; Schürer, Stephan C SC; Dubovy, Sander R SR; Chapman, Jennifer R JR; Vega, Francisco F; Dave, Sandeep S; Lossos, Izidore S IS
Microscaled proteogenomic methods for precision oncology.
Nature Communications
Satpathy, Shankha S; Jaehnig, Eric J EJ; Krug, Karsten K; Kim, Beom-Jun BJ; Saltzman, Alexander B AB; Chan, Doug W DW; Holloway, Kimberly R KR; Anurag, Meenakshi M; Huang, Chen C; Singh, Purba P; Gao, Ari A; Namai, Noel N; Dou, Yongchao Y; Wen, Bo B; Vasaikar, Suhas V SV; Mutch, David D; Watson, Mark A MA; Ma, Cynthia C; Ademuyiwa, Foluso O FO; Rimawi, Mothaffar F MF; Schiff, Rachel R; Hoog, Jeremy J; Jacobs, Samuel S; Malovannaya, Anna A; Hyslop, Terry T; Clauser, Karl R KR; Mani, D R DR; Perou, Charles M CM; Miles, George G; Zhang, Bing B; Gillette, Michael A MA; Carr, Steven A SA; Ellis, Matthew J MJ
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Oncotarget
Raaijmakers, Marieke I G MI; Widmer, Daniel S DS; Narechania, Apurva A; Eichhoff, Ossia O; Freiberger, Sandra N SN; Wenzina, Judith J; Cheng, Phil F PF; Mihic-Probst, Daniela D; Desalle, Rob R; Dummer, Reinhard R; Levesque, Mitchell P MP